Literature DB >> 15897826

The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion.

Akihito Minamide1, Munehito Yoshida, Mamoru Kawakami, Satoru Yamasaki, Hirotsugu Kojima, Hiroshi Hashizume, Scott D Boden.   

Abstract

STUDY
DESIGN: Posterolateral lumbar transverse process fusion was completed using the cultured bone marrow cells in type I collagen gel and porous hydroxyapatite.
OBJECTIVE: To compare the efficacy of cultured bone marrow cells with that of bone morphogenetic protein (BMP) as a graft alternative to autologous bone for posterolateral spine fusion. SUMMARY OF BACKGROUND DATA: The clinical application of BMP for spinal fusion may be limited by high dose and cost. Recently, mesenchymal stem cells have been studied in various fields because of their capability to differentiate into various cells, including those in the osteogenic lineage.
METHODS: Thirty adult rabbits were used. Each underwent single-level, bilateral, posterolateral intertransverse process fusions at L4-L5. The animals were divided into 4 groups, each according to the material implanted: (1) autologous bone (autograft, n = 9); (2) porous hydroxyapatite (HA) particles and type I collagen sheet with 100 microg rhBMP-2 (BMP-HA, n = 7); (3) bone marrow cells (1 x 10(6) cells/mL, low-marrow-HA, n = 7); and (4) bone marrow cells (1 x 10(8) cells/mL, high-marrow-HA, n = 7). Before implantation for groups 3 and 4, fresh bone marrow cells from the iliac crest of each animal were cultured in a standard medium for 2 weeks. For one additional week, the marrow cells were cultured in 10(-8) M dexamethasone, type I collagen gel, and HA. Animals were euthanized 6 weeks after surgery. Spinal fusions were evaluated by radiograph, manual palpation, and histology.
RESULTS: The fusion rates were 4 of 7 in the autograft group, 7 of 7 in the BMP-HA group, 0 of 7 in the low-marrow-HA group, and 5 of 7 in the high-marrow-HA group. The histology in the BMP-HA and high-marrow-HA groups showed that grafted HA fragments were connected with mature new bone. The pores of HA fragments were filled up with bone matrix. In the low-marrow-HA group, fibrous tissue was predominant in the grafted fragments.
CONCLUSIONS: This study shows that the cultured bone marrow cells can act as a substitute for autograft or BMP in spine fusion. The current formulation may yield improved fusion success and better quality of fusion bone as compared to autograft.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15897826     DOI: 10.1097/01.brs.0000162394.75425.04

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  23 in total

Review 1.  An update on bone substitutes for spinal fusion.

Authors:  Masashi Miyazaki; Hiroshi Tsumura; Jeffrey C Wang; Ahmet Alanay
Journal:  Eur Spine J       Date:  2009-03-12       Impact factor: 3.134

2.  Far-red fluorescence gene reporter tomography for determination of placement and viability of cell-based gene therapies.

Authors:  Yujie Lu; Chinmay D Darne; I-Chih Tan; Banghe Zhu; Mary A Hall; Zawaunyka W Lazard; Alan R Davis; Lashan Simpson; Eva M Sevick-Muraca; Elizabeth A Olmsted-Davis
Journal:  Opt Express       Date:  2013-10-07       Impact factor: 3.894

Review 3.  Stem cells for spine surgery.

Authors:  Joshua Schroeder; Janina Kueper; Kaplan Leon; Meir Liebergall
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

4.  Cell Cultivation on Porous Titanium Implants with Various Structures.

Authors:  M I Blinova; N M Yudintzeva; N S Nikolaenko; I L Potokin; G Raykhtsaum; M R Pitkin; G P Pinaev
Journal:  Cell tissue biol       Date:  2010

Review 5.  The role of stem cell therapies in degenerative lumbar spine disease: a review.

Authors:  David Oehme; Tony Goldschlager; Jeffrey V Rosenfeld; Peter Ghosh; Graham Jenkin
Journal:  Neurosurg Rev       Date:  2015-03-07       Impact factor: 3.042

Review 6.  History of Spinal Fusion: Where We Came from and Where We Are Going.

Authors:  Sohrab Virk; Sheeraz Qureshi; Harvinder Sandhu
Journal:  HSS J       Date:  2020-02-25

Review 7.  Cellular bone matrices: viable stem cell-containing bone graft substitutes.

Authors:  Branko Skovrlj; Javier Z Guzman; Motasem Al Maaieh; Samuel K Cho; James C Iatridis; Sheeraz A Qureshi
Journal:  Spine J       Date:  2014-06-11       Impact factor: 4.166

8.  The effect of NELL1 and bone morphogenetic protein-2 on calvarial bone regeneration.

Authors:  Tara Aghaloo; Catherine M Cowan; Xinli Zhang; Earl Freymiller; Chia Soo; Benjamin Wu; Kang Ting; Zhiyuan Zhang
Journal:  J Oral Maxillofac Surg       Date:  2010-02       Impact factor: 1.895

9.  Effect of hyperbaric oxygen on mesenchymal stem cells for lumbar fusion in vivo.

Authors:  Tsai-Sheng Fu; Steve W N Ueng; Tsung-Ting Tsai; Lih-Huei Chen; Song-Shu Lin; Wen-Jer Chen
Journal:  BMC Musculoskelet Disord       Date:  2010-03-19       Impact factor: 2.362

10.  Evaluation of Spinal Fusion Using Bone Marrow Derived Mesenchymal Stem Cells with or without Fibroblast Growth Factor-4.

Authors:  Hyun Sung Seo; Jong Kwon Jung; Mi-Hyun Lim; Dong Keun Hyun; Nam-Sik Oh; Seung Hwan Yoon
Journal:  J Korean Neurosurg Soc       Date:  2009-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.